Iterum Therapeutics PLC
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Iterum Therapeutics PLC
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
/ 
Frequently asked questions
To buy Iterum Therapeutics PLC stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Iterum Therapeutics PLC by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Iterum Therapeutics PLC is ITRM:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Iterum Therapeutics PLC has its primary listing on NASDAQ. You can trade Iterum Therapeutics PLC with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Iterum Therapeutics PLC is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Iterum Therapeutics PLC as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Iterum Therapeutics PLC.